Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05884775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05884775 · ClinicalTrials.gov record · last posted 2026-08-27

Novel Digital Patient-Reported Outcomes Tool for Diabetes Management

StatusTerminated
PhaseNot applicable
Started2025-11-04
View on ClinicalTrials.gov ↗
Why the trial stopped
Funding was terminated for the study.
from the ClinicalTrials.gov record
Investigators will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial (RCT) to evaluate the effectiveness of iMatter2 versus usual care on reduction in HbA1c at 12-months (primary outcome) among patients with Type 2 diabetes (T2D).

Protocol amendment history 5 changes detected by DataLookout

2026-08-28
Trial terminated
2026-08-28
Trial terminated: Funding was terminated for the study.
2026-08-28
Enrollment reduced: 353 → 37 participants
2026-08-28
Primary completion moved earlier: 2028-03-31 → 2026-05-19
2026-08-28
Completion moved earlier: 2028-05-31 → 2026-06-19
Trial Details
NCT Number NCT05884775
Lead Sponsor NYU Langone Health
Conditions Type 2 Diabetes
Enrollment 37 participants
Start Date 2025-11-04
Primary Completion 2026-05-19 (estimated)
Study Completion 2026-06-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-27